EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

Romain Chopard iD, Raquel Morillo, Nicolas Meneveau, David Jiménez

Hämostaseologie · 2024-06 · 44 (03) · 182-192

DOI: 10.1055/a-2215-9003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hämostaseologie, online erschienen am 26.03.2024. Verfasst von Romain Chopard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Besançon, Besançon, France. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Pulmonary Embolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-risk pulmonary embolism (PE) refers to a large embolic burden causing right ventricular failure and hemodynamic instability. It accounts for approximately 5% of all cases of PE but contributes significantly to overall PE mortality. Systemic thrombolysis is the first-line revascularization therapy in high-risk PE. Surgical embolectomy or catheter-directed therapy is recommended in patients with an absolute contraindication to systemic thrombolysis. Extracorporeal membrane oxygenation (ECMO) provides respiratory and hemodynamic support for the most critically ill PE patients with refractory cardiogenic shock or cardiac arrest. The complex management of these individuals requires urgent yet coordinated multidisciplinary care. In light of existing evidence regarding the utility of ECMO in the management of high-risk PE patients, a number of possible indications for ECMO utilization have been suggested in the literature. Specifically, in patients with refractory cardiac arrest, resuscitated cardiac arrest, or refractory shock, including in cases of failed thrombolysis, venoarterial ECMO (VA-ECMO) should be considered, either as a bridge to percutaneous or surgical embolectomy or as a bridge to recovery after surgical embolectomy. We review here the current evidence on the use of ECMO as part of the management strategy for the highest-risk presentations of PE and summarize the latest data in this indication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationPulmonary EmbolismHumansEmbolectomyShock, CardiogenicTreatment OutcomeThrombolytic Therapy

Autor:innen und Institutionen

  • Department of Cardiology, University Hospital Besançon, Besançon, France.
  • SINERGIES, University of Franche-Comté, Besançon, France.
  • F-CRIN, INNOVTE network, France.
  • Respiratory Department, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Medicine Department, Universidad de Alcalá, (IRYCIS) Madrid, Spain.

ORCID-Profile: Romain Chopard

Zitieren

APA

Chopard, R., Morillo, R., Meneveau, N., & Jiménez, D. (2024). Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence. Hämostaseologie, 44(03), 182-192. https://doi.org/10.1055/a-2215-9003

Vancouver

Chopard R, Morillo R, Meneveau N, Jiménez D. Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence. Hämostaseologie. 2024;44(03):182-192. doi:10.1055/a-2215-9003

BibTeX
@article{Chopard2024,
  author = {Chopard, Romain and Morillo, Raquel and Meneveau, Nicolas and Jiménez, David},
  title = {Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence},
  journal = {Hämostaseologie},
  year = {2024},
  volume = {44},
  number = {03},
  pages = {182--192},
  doi = {10.1055/a-2215-9003}
}
Kostenlos starten →